Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenues
Gross Profit
Operating expenses:        
Marketing expenses 400 505
Research and development 49,659 91,259 1,978
General and administrative 523,704 202,577 1,326,019 569,384
Total operating expenses 573,363 202,977 1,417,278 571,867
Loss from operations (573,363) (202,977) (1,417,278) (571,867)
Other expense:        
Interest expense 29,095 29,095
Interest expense - debt discount 49,749 82,915 286,391 210,836
Interest expense - original issuance costs 13,697 10,098 44,683 24,865
Total other expense 92,541 93,013 360,169 235,701
Loss before income taxes (665,904) (295,990) (1,777,447) (807,568)
Income taxes
Net loss $ (665,904) $ (295,990) $ (1,777,447) $ (807,568)
Net loss per share, basic and diluted $ (0.02) $ (0.59) $ (0.05) $ (1.62)
Weighted average number of shares outstanding        
Basic and diluted 36,721,651 500,000 36,138,191 500,000